Location History:
- Ellerstadt, GB (2014)
- Sheffield, GB (2013 - 2022)
Company Filing History:
Years Active: 2013-2022
Title: Innovative Contributions of Gareth Owain Richards
Introduction
Gareth Owain Richards, an accomplished inventor based in Ellerstadt, Great Britain, has made significant strides in the field of pharmaceuticals. With a total of four patents to his name, Richards is recognized for his innovative approaches to addressing complex medical conditions, particularly those related to cancer and other proliferative diseases.
Latest Patents
Richards's latest patents showcase his dedication to advancing medical science. One notable patent involves compounds designed to inhibit the adrenomedullin receptor subtype 2 (AM). These compounds can be utilized in treating diseases modulated by AM, including various forms of cancer. They encompass pharmaceutical compositions, methods for preparation, and intermediates essential for their synthesis.
Another innovative patent features agents that modulate the effects of Receptor Activity Modifying Protein (RAMP) on the Calcitonin Receptor Like Receptor (CRLR). These agents offer potential therapeutic applications in treating cancer, obesity, and other disorders. The patent also outlines methods and assays for identifying these beneficial agents.
Career Highlights
Richards has contributed his expertise to several esteemed institutions. His career includes significant roles at Medella Therapeutics Limited and the University of Sheffield. His professional experiences have allowed him to further develop his inventive concepts and drive impactful research in the medical field.
Collaborations
Throughout his career, Richards has had the opportunity to collaborate with notable individuals, including Timothy Michael Skerry and Joseph P A Harrity. Their teamwork has been instrumental in advancing innovative projects that address critical health challenges.
Conclusion
Gareth Owain Richards stands out as a dedicated inventor whose work has the potential to facilitate significant advancements in medical treatments. With a promising portfolio of patents and collaborations with leading professionals, he continues to contribute to the evolution of healthcare solutions.